Are you Dr. Schrader?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4101 Greenbriar St
#200
Houston, TX 77098Phone+1 713-526-7736Fax+1 713-524-3155
Summary
- Dr. Shannon Schrader, MD is a board certified family physician in Houston, Texas. He is currently licensed to practice medicine in Texas, Maine, and Pennsylvania. He is affiliated with HCA Houston Healthcare Medical Center and St. Luke's Health - Baylor St. Luke's Medical Center.
Education & Training
- Baylor College of MedicineResidency, Family Medicine, 1989 - 1992
- University of Louisville School of MedicineClass of 1989
Certifications & Licensure
- ME State Medical License 2007 - 2026
- TX State Medical License 1990 - 2026
- NY State Medical License 1993 - 2017
- PA State Medical License 1994 - 2000
- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Solution Series EHR, e-MDs, 2011
- Super Doctor SuperDoctors.com
Clinical Trials
- Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV Start of enrollment: 2015 Aug 01
- Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1 Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- 23 citationsVirological and immunological responses to once-daily dosing of didanosine in combination with stavudineJane E. Mobley, Richard B. Pollard, Shannon Schrader, Myra Adler, Thomas Kelleher
AIDS. 1999-07-30 - 82 citationsTherapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trialDavid W. Haas, Carlos Zala, Shannon Schrader, Peter J. Piliero, H Jaeger
AIDS. 2003-06-13 - 33 citationsCD4 Cell Response to 3 Doses of Subcutaneous Interleukin 2: Meta-analysis of 3 Vanguard StudiesRoberto C. Arduino, Esteban C. Mannini, Maria C. Rodriguez-Barradas, Shannon Schrader, Marcelo H. Losso
Clinical Infectious Diseases. 2004-07-01